# Clinical and Biological Efficacy of Mirasol-treated Fresh Whole Blood for the Prevention of Transfusion-transmitted Malaria

> **NCT02118428** · NA · COMPLETED · sponsor: **Terumo BCTbio** · enrollment: 227 (actual)

## Conditions studied

- Malaria

## Interventions

- **DEVICE:** Mirasol-treated Whole Blood
- **BIOLOGICAL:** Untreated Whole Blood

## Key facts

- **NCT ID:** NCT02118428
- **Lead sponsor:** Terumo BCTbio
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 227 (ACTUAL)
- **Last updated:** 2019-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02118428

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02118428, "Clinical and Biological Efficacy of Mirasol-treated Fresh Whole Blood for the Prevention of Transfusion-transmitted Malaria". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT02118428. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*